You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Mantle Cell Lymphoma Treatment Market Research Report 2021, Competitive Analysis, Industry Growth Trends And Forecast 2027

Market Analysis and Insights: Global Mantle Cell Lymphoma Treatment Market
The research report studies the Mantle Cell Lymphoma Treatment market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Mantle Cell Lymphoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Mantle Cell Lymphoma Treatment Scope and Segment
The global Mantle Cell Lymphoma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Mantle Cell Lymphoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
by Type, the market is primarily split into
Acalabrutinib
JCAR-017
JNJ-64052781
Acalisib
IGN-002
IMGN-529
AFM-11
Others
by Application, this report covers the following segments
Hospital
Clinic
Others
Global Mantle Cell Lymphoma Treatment market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Mantle Cell Lymphoma Treatment key players in this market include:
Astex Pharmaceuticals, Inc.
Bayer AG
Bristol-Myers Squibb Company
Celgene Corporation
Cellular Biomedicine Group, Inc.
Eisai
EpiZyme, Inc.
Fate Therapeutics, Inc.
Genentech, Inc.
Gilead Sciences, Inc.
GlaxoSmithKline Plc
Hutchison MediPharma Limited
ImmunoGen, Inc.
Immunomedics, Inc.
1 Market Overview of Mantle Cell Lymphoma Treatment
1.1 Mantle Cell Lymphoma Treatment Market Overview
1.1.1 Mantle Cell Lymphoma Treatment Product Scope
1.1.2 Mantle Cell Lymphoma Treatment Market Status and Outlook
1.2 Global Mantle Cell Lymphoma Treatment Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Mantle Cell Lymphoma Treatment Market Size by Region (2016-2027)
1.4 Global Mantle Cell Lymphoma Treatment Historic Market Size by Region (2016-2021)
1.5 Global Mantle Cell Lymphoma Treatment Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Mantle Cell Lymphoma Treatment Market Size (2016-2027)
1.6.1 North America Mantle Cell Lymphoma Treatment Market Size (2016-2027)
1.6.2 Europe Mantle Cell Lymphoma Treatment Market Size (2016-2027)
1.6.3 Asia-Pacific Mantle Cell Lymphoma Treatment Market Size (2016-2027)
1.6.4 Latin America Mantle Cell Lymphoma Treatment Market Size (2016-2027)
1.6.5 Middle East & Africa Mantle Cell Lymphoma Treatment Market Size (2016-2027)
2 Mantle Cell Lymphoma Treatment Market Overview by Type
2.1 Global Mantle Cell Lymphoma Treatment Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Mantle Cell Lymphoma Treatment Historic Market Size by Type (2016-2021)
2.3 Global Mantle Cell Lymphoma Treatment Forecasted Market Size by Type (2022-2027)
2.4 Acalabrutinib
2.5 JCAR-017
2.6 JNJ-64052781
2.7 Acalisib
2.8 IGN-002
2.9 IMGN-529
2.10 AFM-11
2.11 Others
3 Mantle Cell Lymphoma Treatment Market Overview by Application
3.1 Global Mantle Cell Lymphoma Treatment Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Mantle Cell Lymphoma Treatment Historic Market Size by Application (2016-2021)
3.3 Global Mantle Cell Lymphoma Treatment Forecasted Market Size by Application (2022-2027)
3.4 Hospital
3.5 Clinic
3.6 Others
4 Mantle Cell Lymphoma Treatment Competition Analysis by Players
4.1 Global Mantle Cell Lymphoma Treatment Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Mantle Cell Lymphoma Treatment as of 2020)
4.3 Date of Key Players Enter into Mantle Cell Lymphoma Treatment Market
4.4 Global Top Players Mantle Cell Lymphoma Treatment Headquarters and Area Served
4.5 Key Players Mantle Cell Lymphoma Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Mantle Cell Lymphoma Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Astex Pharmaceuticals Inc.
5.1.1 Astex Pharmaceuticals Inc. Profile
5.1.2 Astex Pharmaceuticals Inc. Main Business
5.1.3 Astex Pharmaceuticals Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
5.1.4 Astex Pharmaceuticals Inc. Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2016-2021)
5.1.5 Astex Pharmaceuticals Inc. Recent Developments
5.2 Bayer AG
5.2.1 Bayer AG Profile
5.2.2 Bayer AG Main Business
5.2.3 Bayer AG Mantle Cell Lymphoma Treatment Products, Services and Solutions
5.2.4 Bayer AG Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2016-2021)
5.2.5 Bayer AG Recent Developments
5.3 Bristol-Myers Squibb Company
5.3.1 Bristol-Myers Squibb Company Profile
5.3.2 Bristol-Myers Squibb Company Main Business
5.3.3 Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Products, Services and Solutions
5.3.4 Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2016-2021)
5.3.5 Celgene Corporation Recent Developments
5.4 Celgene Corporation
5.4.1 Celgene Corporation Profile
5.4.2 Celgene Corporation Main Business
5.4.3 Celgene Corporation Mantle Cell Lymphoma Treatment Products, Services and Solutions
5.4.4 Celgene Corporation Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2016-2021)
5.4.5 Celgene Corporation Recent Developments
5.5 Cellular Biomedicine Group Inc.
5.5.1 Cellular Biomedicine Group Inc. Profile
5.5.2 Cellular Biomedicine Group Inc. Main Business
5.5.3 Cellular Biomedicine Group Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
5.5.4 Cellular Biomedicine Group Inc. Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2016-2021)
5.5.5 Cellular Biomedicine Group Inc. Recent Developments
5.6 Eisai
5.6.1 Eisai Profile
5.6.2 Eisai Main Business
5.6.3 Eisai Mantle Cell Lymphoma Treatment Products, Services and Solutions
5.6.4 Eisai Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2016-2021)
5.6.5 Eisai Recent Developments
5.7 EpiZyme Inc.
5.7.1 EpiZyme Inc. Profile
5.7.2 EpiZyme Inc. Main Business
5.7.3 EpiZyme Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
5.7.4 EpiZyme Inc. Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2016-2021)
5.7.5 EpiZyme Inc. Recent Developments
5.8 Fate Therapeutics Inc.
5.8.1 Fate Therapeutics Inc. Profile
5.8.2 Fate Therapeutics Inc. Main Business
5.8.3 Fate Therapeutics Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
5.8.4 Fate Therapeutics Inc. Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2016-2021)
5.8.5 Fate Therapeutics Inc. Recent Developments
5.9 Genentech Inc.
5.9.1 Genentech Inc. Profile
5.9.2 Genentech Inc. Main Business
5.9.3 Genentech Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
5.9.4 Genentech Inc. Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2016-2021)
5.9.5 Genentech Inc. Recent Developments
5.10 Gilead Sciences Inc.
5.10.1 Gilead Sciences Inc. Profile
5.10.2 Gilead Sciences Inc. Main Business
5.10.3 Gilead Sciences Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
5.10.4 Gilead Sciences Inc. Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2016-2021)
5.10.5 Gilead Sciences Inc. Recent Developments
5.11 GlaxoSmithKline Plc
5.11.1 GlaxoSmithKline Plc Profile
5.11.2 GlaxoSmithKline Plc Main Business
5.11.3 GlaxoSmithKline Plc Mantle Cell Lymphoma Treatment Products, Services and Solutions
5.11.4 GlaxoSmithKline Plc Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2016-2021)
5.11.5 GlaxoSmithKline Plc Recent Developments
5.12 Hutchison MediPharma Limited
5.12.1 Hutchison MediPharma Limited Profile
5.12.2 Hutchison MediPharma Limited Main Business
5.12.3 Hutchison MediPharma Limited Mantle Cell Lymphoma Treatment Products, Services and Solutions
5.12.4 Hutchison MediPharma Limited Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2016-2021)
5.12.5 Hutchison MediPharma Limited Recent Developments
5.13 ImmunoGen Inc.
5.13.1 ImmunoGen Inc. Profile
5.13.2 ImmunoGen Inc. Main Business
5.13.3 ImmunoGen Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
5.13.4 ImmunoGen Inc. Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2016-2021)
5.13.5 ImmunoGen Inc. Recent Developments
5.14 Immunomedics Inc.
5.14.1 Immunomedics Inc. Profile
5.14.2 Immunomedics Inc. Main Business
5.14.3 Immunomedics Inc. Mantle Cell Lymphoma Treatment Products, Services and Solutions
5.14.4 Immunomedics Inc. Mantle Cell Lymphoma Treatment Revenue (US$ Million) & (2016-2021)
5.14.5 Immunomedics Inc. Recent Developments
6 North America
6.1 North America Mantle Cell Lymphoma Treatment Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Mantle Cell Lymphoma Treatment Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Mantle Cell Lymphoma Treatment Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Mantle Cell Lymphoma Treatment Market Dynamics
11.1 Mantle Cell Lymphoma Treatment Industry Trends
11.2 Mantle Cell Lymphoma Treatment Market Drivers
11.3 Mantle Cell Lymphoma Treatment Market Challenges
11.4 Mantle Cell Lymphoma Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
  • FORMAT: PDF
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 125